Abstract
In vitro angiogenesis assays are essential for the identification of potential angiogenic agents and screening for pharmacological inhibitors. Among these assays, the rat aortic ring model developed by Nicosia bridges the gap between in vivo and in vitro models. The quantification of angiogenesis on this system must be applicable to characterise vascular networks of various states of complexity. We present here an improved computer-assisted image analysis which allows: (1) the determination of the aortic ring area and its factor shape; (2) the number of microvessels, the total number of branchings, the maximal microvessel length and the microvessel distribution; (3) the total number of isolated fibroblast-like cells and their distribution. We show that this method is suitable to quantify spontaneous angiogenesis as well as to analyse a complex microvascular network induced by various concentrations of vascular endothelial growth factor (VEGF). In addition, by evaluating a new parameter, the fibroblast-like cell distribution, our results show that: (1) during spontaneous angiogenic response, maximal fibroblast-like cell migration delimits microvascular outgrowth; and (2) the known angiogenic inhibitor Batimastat prevents endothelial cell sprouting without completely blocking fibroblast-like cell migration. Finally, this new method of quantification is of great interest to better understand angiogenesis and to test pro- or anti-angiogenic agents.
Similar content being viewed by others
References
Folkman J, Brem H. Angiogenesis and inflammation. In Gallin JI, Goldstein IM, Snyderman RS (eds): Inflammation: Basic Principles and Clinical Correlates. New York: Raven Press 1996; 809–39.
Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1995; 1: 27–31.
Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442–7.
Auerbach R, Auerbach W, Polakowski I. Assays of angiogenesis: A review. Pharmacol Ther 1991; 51: 1–11.
Nicosia RF, Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta: A quantitative assay of angiogenesis in vitro. Lab Invest 1990; 63: 115–22.
Kobayashi S, Fukuta M, Kontani H et al. A quantitative assay for angiogenesis of cultured choroidal tissues in streptozotocin-diabetic wistar and spontaneously diabetic GK rats. Jpn J Pharmacol 1998; 78: 471–8.
Brown KJ, Maynes SF, Bezos A et al. A novel in vitro assay for human angiogenesis. Lab Invest 1996; 75: 539–55.
Bocci G, Danesi R, Benelli U et al. Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo. Cancer Chemother Pharmacol 1999; 43: 205–12.
Kruger EA, Duray PH, Tkosos MG et al. Endostatic inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assay. Biochem Biophys Res Commun 2000; 268: 183–91.
Nissanov J, Tuman RW, Gruver LM, Fortunato JM. Automatic vessel segmentation and quantification of the rat aortic ring assay of angiogenesis. Lab Invest 1995; 73: 734–9.
Montesano R, Orci L, Vassali P. In vitro rapid organisation of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol 1983; 97: 1648–52.
Serra J. Image Analysis and Mathematical Morphology, Vol 1. New York: Academic Press 1982.
Voyta JC, Via DP, Butterfield CE, Zetter BR. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 1984; 99: 2034–40.
Himmelblau DM. Process Analysis by Statistical Methods. New York: Wiley 1970.
Belotti D, Paganoni P, Giavazzi R. MMP inhibitors: Experimental and clinical studies. Int J Biol Markers 1999; 14: 232–8.
Moses MA. The regulation of neovascularization by matrix metalloproteinases and their inhibitors. Stem Cells 1997; 15: 180–9.
Botos I, Scappozza L, Zhang D. Batimastat, a potent matrix metalloproteinase inhibitor, exhibits an unexpected mode of binding. Proc Natl Acad Sci USA 1996; 39: 2749–54.
Carmeliet P, Collen D. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr Top Microbiol Immunol 1999; 237: 133–58.
Benelli R, Albini A. In vitro models of angiogenesis: The use of Matrigel. Int J Biol Markers 1999; 14: 243–6.
Ribatti D, Vacca A, Wild R et al. Models for studying angiogenesis in vivo. Int J Biol Markers 1999; 14: 207–13.
Chambers AF, MacDonald IC, Schmidt EE et al. Clinical targets for anti-metastasis therapy. Adv Cancer Res 2000; 79: 91–121.
Jain RK, Schlenger K, Höckel M, Yuan F. Quantitative angiogenesis assays: Progress and problems. Nat Med 1997; 3: 1203–8.
Carmeliet P, Moons L, Luttun A et al. Synergism between VEGF and Placental Growth Factor (PIGF) contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 5: 75–83.
Nicosia RF, Villaschi S. Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro. Lab Invest 1995; 73: 658–66.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blacher, S., Devy, L., Burbridge, M.F. et al. Improved quantification of angiogenesis in the rat aortic ring assay. Angiogenesis 4, 133–142 (2001). https://doi.org/10.1023/A:1012251229631
Issue Date:
DOI: https://doi.org/10.1023/A:1012251229631